Table 2.
Step | Parameter | 96-well plate | 384-well plate | Description |
---|---|---|---|---|
1 | Plate cells | 50 μL | 12.5 μL | 50,000 cells/well for 96-well plate; 12,500 cells/well for 384-well plate |
2 | Controls | 50 μL | 12.5 μL | DMSO, 17-AAG, 174 |
3 | Library compounds | 50 μL | 12.5 μL | Dilution range 1.2 nM–25 μM |
4 | Incubation time | 1 h | 1 h | 37°C, 5% CO2 |
5 | Reporter reagent | 100 μL | 50 μL | Luciferin substrate |
6 | Assay readout | CCD imager, luminescent mode |
Step Notes
1. Prepare drug plates in DMSO by serial dilution of 20 mM drug stocks (dilution range 100 nM–2 mM). Final volume is 30 μL for 96-well plate or 20 μL for 384-well plate.
2. Dilute control and test compounds from drug plates in media to make dilution plates. Final volume is 200 μL for 96-well plate or 80 μL for 384-well plate.
3. Add drug in media from dilution plate to 96-well plate (Costar 96-well white opaque plate) or 384-well plate (Corning 384-well black plate with clear bottom) at the volume indicated earlier.
4. Add heat-treated (50°C) cells to each well of cell plate at the volume and concentration indicated earlier.
5. Incubate plate at 37°C for 1 h.
6. Add reporter reagent (75 mM tricine, pH 7.8, 24 mM MgSO4, 0.3 mM EDTA, 2 mM DTT, 0.313 mM luciferin, 0.64 mM coenzyme A, 0.66 mM ATP, 150 mM KCl, 10% Triton X-100, 20% glycerol, and 3.5% DMSO) at the volume indicated earlier. Shake plate for 2 min.
7. Read luciferase activity (relative light units, Rel. LU) across plate.